Halda is inventing novel precision medicines for oncology.  Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic disease drivers to target cancer.  This powerful technology is designed to overcome the known bypass mechanisms of drug resistance, a common limitation of today’s precision cancer medicines.  Using a novel ‘hold and kill’ mechanism, RIPTAC therapeutics target cancer cells selectively by bringing two proteins together in a tightly regulated manner, causing the loss of an essential function for cell survival and subsequent cancer cell death. 

We have built a pipeline of RIPTAC therapeutics for major cancer types, uniquely addressing the unmet needs of drug resistant cancer patients, and we will continue to invent new medicines using our proprietary platform technology. 

We are a bold company where collaboration, passion, and creativity thrive, all of which allows us to push the boundaries of drug discovery to identify better solutions. 

Halda is proud to be a New Haven, CT based biotech, located with headquarters and state-of-the-art labs in Science Park.


Biotechnology

Halda Therapeutics

Craig Crews

Scott Phillips

Kat Kayser-Bricker

The Research and Development team at Halda Therapeutics is dedicated to the discovery and advancement of innovative RIPTAC™ therapeutics for oncology. Comprising skilled scientists and researchers, the team conducts cutting-edge experiments to understand the mechanisms of cancer and to develop targeted treatments that effectively overcome drug resistance. Their collaborative efforts focus on advancing the company's pipeline of precision medicines, ultimately aiming to provide novel solutions for patients suffering from drug-resistant cancers.

Research and Development

About

Team members

Other teams at Halda Therapeutics

Research and Development

Leadership Team